Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

ATM controls meiotic double-strand-break formation.

Nature | 2011

In many organisms, developmentally programmed double-strand breaks (DSBs) formed by the SPO11 transesterase initiate meiotic recombination, which promotes pairing and segregation of homologous chromosomes. Because every chromosome must receive a minimum number of DSBs, attention has focused on factors that support DSB formation. However, improperly repaired DSBs can cause meiotic arrest or mutation; thus, having too many DSBs is probably as deleterious as having too few. Only a small fraction of SPO11 protein ever makes a DSB in yeast or mouse and SPO11 and its accessory factors remain abundant long after most DSB formation ceases, implying the existence of mechanisms that restrain SPO11 activity to limit DSB numbers. Here we report that the number of meiotic DSBs in mouse is controlled by ATM, a kinase activated by DNA damage to trigger checkpoint signalling and promote DSB repair. Levels of SPO11-oligonucleotide complexes, by-products of meiotic DSB formation, are elevated at least tenfold in spermatocytes lacking ATM. Moreover, Atm mutation renders SPO11-oligonucleotide levels sensitive to genetic manipulations that modulate SPO11 protein levels. We propose that ATM restrains SPO11 via a negative feedback loop in which kinase activation by DSBs suppresses further DSB formation. Our findings explain previously puzzling phenotypes of Atm-null mice and provide a molecular basis for the gonadal dysgenesis observed in ataxia telangiectasia, the human syndrome caused by ATM deficiency.

Pubmed ID: 22002603 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NICHD NIH HHS, United States
    Id: R01 HD040916
  • Agency: NICHD NIH HHS, United States
    Id: HD053855
  • Agency: Howard Hughes Medical Institute, United States
  • Agency: NICHD NIH HHS, United States
    Id: HD040916
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD053855-01A1
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM058673-01
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM058673
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD053855
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD040916-01
  • Agency: NICHD NIH HHS, United States
    Id: F32 HD051392
  • Agency: NICHD NIH HHS, United States
    Id: F32HD5139
  • Agency: NIGMS NIH HHS, United States
    Id: GM058673

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


New England Biolabs (tool)

RRID:SCR_013517

An Antibody supplier

View all literature mentions